• Stock Chart

    Stock Chart

    Propanc Biopharma, Inc.(PPCB)

    US OTC

    $0.0016

    0.0001(6.667%)

    PPCB Company Profile

    6 Butler Street

    Camberwell, Victoria (VIC)
    61.3.9882.0780
    http://www.propanc.com
    Sector: Health Technology
    Industry: Pharmaceuticals: Other
    Full Time Employees: 3

    Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The company focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.

    • Previous Close
      0.0015
    • Open
      0.0017
    • Bid
    • Ask
    • Day's Range
      0.0015 - 0.0017
    • 52 week Range
      0.0013 - 1.89
    • Volume
      43844430
    • Avg. Volume
      48117474
    • Market Cap
      157370
    • Beta (5Y Monthly)
      0.0017
    • PE Ratio (TTM)
      0
    • EPS (TTM)
    • Earnings Date
      0.0017
    • Forward Dividend & Yield
      0.0017
    • Ex-Dividend Date
      43844430
    • 1y Target Est
      0.0017

    KEEP ME INFORMED ON PPCB UPDATES

    PPCB Performance

    • 5 Day
      -25%
    • 1 Month
      -48.2759%
    • 3 Month
      -89.2086%
    • YTD
      -99.8%
    • 1 Year
      -99.8966%

    PPCB on Twitter

    PPCB on iHub

    PPCB News

    /*
  • */